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Abstract 
 
DNA damage usually happens due to the several chemical materials that induce genotoxic effect in 
normal cells. Cinnamon essential oil (CEO), which contains cinnamaldehyde as its major compound, has 
been reported to possess antioxidant activity to prevent DNA damage. The aim of this study is to 
evaluate the genotoxic and cytotoxic effect of CEO on doxorubicin-induced Chinese Hamster Ovary 
(CHO-K1) cells. The cytotoxic effect of CEO was determined by MTT assay with the parameter of IC50 
while the genotoxic effect was carried out by micronucleus (MN) assay by using acridine orange 
fluorescent staining with the parameter of MN/1000 cells reduction number. Based on MTT assay, CEO 
showed cytotoxic activity with the IC50 value of 30 μg/mL and for MN assay, 3 μg/mL (1/10 IC50) of CEO 
decreased the percentage of micronucleus per 1000 cells up to 94.55%. Thus, the result can be 
summarized that CEO does not induce genotoxic and has the potency to prevent DNA damage caused by 
doxorubicin on CHO-K1 cells.  
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INTRODUCTION 
 
Genotoxic compounds are widely known to 
interact with DNA/RNA, causing disrupt genetic 
codes in the chromosome (Guengerich, 1992). 
Carcinogens, mutagens or teratogens cause genetic 
mutation in cells and other biological systems (Shah, 
2012). Moreover, genotoxic compounds also lead to 
various degenerative diseases such as cancer, 
atherosclerosis, arthritis, neurodegenerative 
disorders and other serious diseases (Bonassi, et al., 
2011).  
Development of antigenotoxic agent could 
reduce genotoxicity. Some natural product have 
potential as antigenotoxic agent, suc as 
Cinnamomum burmannii. The major compound of 
C. burmannii, cinnamaldehyde, has been explored in 
several studies as antioxidant (Al-Dhubiab, 2012). C. 
burmannii extract was reported to inhibit lipo-
polysaccharide-induced nitric oxide release and 
showed antioxidant activity on RAW264.7 cell, 
possibly mediated through the evaluation of free 
radical scavenging activity and reducing power 
(Choi, et al., 2005). 
The aim of this study was to evaluate the 
antigenotoxic activity of cinnamon essential oil 
(CEO) using CHO-K1 cells induced by doxorubicin. 
This study is expected to be a scientific reference 
prevent degenerative diseases through inhibition og 
genotoxic effects. 
 
MATERIALS AND METHODS 
 
Sample Preparation 
The bark of C. burmanii were collected from 
Yogyakarta and determined in Pharmacognosy 
Laboratory, Faculty of Pharmacy Universitas Gadjah 
Mada. CEO was extracted using steam-destilation 
method. Briefly, 3 kg of C. burmannii was placed in 
large metal vessel. Destilation occurred for 5 hours 
and CEO was collected. CEO then dissolved in 
Dimethyl Sulfoxide (DMSO) (Sigma) for further 
experiment using cells culture. 
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Cell culture 
CHO-K1 cells were obtanined from Cancer 
Cancer Chemoprevention Research Center, 
Yogyakarta. The cells were maintained in RPMI 
medium (Gibco), supplemented with 10% 
v
/v Fetal 
Bovine Serum (FBS) (Sigma) and 1% 10.000 
unit/ml Penicillin-Streptomycin.  
Cell were routinely grown in 10 cm
2 
tissue 
culture disk and kept in a humidified atmosphere of 
5% CO2 at 37
o
C. Cells were harvested with a 
solution of 0.25% Trypsin-EDTA (Gibco) when they 
were in a log phase of growth, and maintained at the 
above-described culture conditions for all 
experiments.   
 
Cell viability assay 
Cell viability was determined using MTT 
assay as performed by Mosmann (1983) with slight 
modification. Cells were seeded into a 96-well plate 
(briefly 8000 cells per well) and incubated for 24 h. 
After rinsing the cells using PBS, cells were treated 
with various concentration of CEO and doxorubicin. 
Certain concentration of either single or combination 
of samples were the applied. After 24 h incubation, 
MTT reagent [3-(4,5-dimethyl-2.thiazolyl)-
2,5diphenyltetrazolium bromide in PBS (5mg/mL)] 
was added 100 µL to each well. The plate was 
incubated in a humidified atmosphere of 5% CO2 at 
37
o
C for 3 h, until formazan crystals was formed 
before dissolved in 100 µL of stopper reagent with 
0.01 N HCl and incubated in dark place for 
overnight. The absorbance of cells was measured at 
595 nm using microplate reader. The data was a 
presented as percentage of viable cells (%).  
 
Acridine orange staining 
Cells (1.2x10
4
 cells/well) were seeded on 
coverslip in 24 well plates until 80% confluent. Cells 
were then incubated 16-24 h, then medium was 
replaced with PBS. Medium and reagents were 
added in the well, then incubated for 28  hours. Cells 
were treated with sample for 24 h at 37
o
C as 
described previously. The next day, the media was 
discarded then the cells were washed using PBS. 
Cells were fixed by methanol, and stained by 
acridine orange. The stained cells then were 
observed under fluoresence microscope with 100x 
magnification.  
 
RESULT AND DISCUSSION 
 
CEO showed Antiproliferative Activity  
Cell viability assay was conducted to 
determine using MTT assay. Based on the result, 
single treatment of CEO and doxorubicin inhibited 
cells growth in dose dependent manner after treated 
for 24 h. The IC50 value of CEO and DOX 
respectively 30 μg/mL and 30 μM.   
 
CEO Reduced the Genotoxic Effect of 
Doxorubicin 
Based on the result, CEO at the concentration 
of 3 μg/mL (1/10 IC50) was able to reduce genotoxic 
effect of doxorubicin on CHO-K1 cells. The green 
fluorescence indicated the expression of viable cells, 
while the small bright spot inside the viable cells 
indicated the micronucleus. The decreasing of 
micronucleus number was related to the suppression 
of genotoxic effect.  
When CEO (3 μg/mL) was in combination 
with doxorubicin (15 μM) showed significantly 
suppression of micronuclei number compared the 
single treatment of doxorubicin. Therefore, CEO 
was able to reduce the genotoxic effect from 
doxorubicin on CHO-K1 cells. 
 
 
 
 
 
 
 
 
 
 
 
Wikanthi, et al., 2017 
Indones. J. Cancer Chemoprevent., 8(1), 27-31  
 
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cell viability assay of CEO. Briefly, 8,000 CHO-K1 cells/well were incubated for 24 h before treated with CEO 
and doxorubicin for 24 h. MTT assay was carried out as mentioned in methods then the absorbance was determined 
using a microplate reader. Cell viability profile after single treatment of doxorubicin (A) and CEO (B). The cells 
morphology of control cell (C), 8 μM of doxorubicin (D), and 20 μg/mL of CEO (E) on CHO-K1 cells after 24 h of 
treatment. Cells photo was captured with 100x magnification which showed morphological changes in cells. The red 
arrow show the morphological changes in cells, while white arrow show the normal cells. 
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Figure 2. CEO Suppression of micronuclei in CHO-K1 Cells. Visualization micronuclei determined by akridin orange 
staining and observed under fluoresence microscope.  
 
 
 
 
DISCUSSION 
 
 Genotoxic compounds are widely known to 
interact with DNA/RNA, causing disrupt genetic 
codes in chromosome (Guengerich, 1992). 
Genotoxicity is determined by micronucleic which 
formed inside the cells when the cells was divided 
incompletely due to the DNA damage. The 
damage caused the gene was unable went towards 
the spindle thread when mitosis was occured. As 
the result, in telophase stage, the nuclear 
membrane was formed which covered the 
defective chromosome DNA and formed a small 
nucleus fragment called micronucleus (Zhou, et 
al., 2000). 
 Cinnamommum burmanii has been known 
to have antioxidant activity. CEO was expected to 
inhibit genotoxicity process and reduce the 
micronucleus. Single cytotoxic test demonstrated 
that CEO inhibited cells proliferation with IC50 
value of 30 μg/mL while doxorubicin with IC50 
value of 30 μM. Related studies has been carried 
out by Larasati (2013) whose using CEO on HeLa 
cells, given IC50 of 250 μg/mL. Doxorubicin was 
used as the model of genotoxic effect in this study 
due to previous studies have been reported that the 
drug is a potent genotoxic anticancer drug that 
generates undesirable effect in health cells by 
creating reactive oxygen species (ROS) (Shi, et al., 
2005). From this study, it can be seen that CEO 
has been able to reduce the micronuclei score in 
CHO-K1 cells. The extracts of C. burmannii was 
reported to inhibit lipo-polysaccharide-induced 
nitric oxide release and showed antioxidant 
activity on RAW264.7 cell, possibly mediated 
through the evaluation of free radical scavenging 
effect and reducing power (Choi, et al., 2005). 
Therefore, CEO possesses its potential as 
antigenotoxic agent through antioxidant activity. 
 
CONCLUSION 
 
CEO inhibit the genotoxic effect of 
doxorubicin and reduce the micronucleus score on 
CHO-K1 cells, thus CEO is potential to be 
developed as an antigenotoxic agent. 
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